6 11, 2017 Elena Ongaro et al., A24Mutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer patients: the ROAD study Diatech Pharmacogenetics2017-11-21T15:16:30+01:00 Read More
18 09, 2017 Graziella Pinotti et al.,1335PEGFR T790M detection in TKI-naïve NSCLCs carrying sensitive EGFR mutations Diatech Pharmacogenetics2017-09-18T14:44:48+02:00 Read More
18 09, 2017 Elena Ongaro et al., 552PMutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer (aCRC) patients (pts): The ROAD study Diatech Pharmacogenetics2020-01-22T09:23:08+01:00 Read More
8 09, 2017 Rossella Bruno et al., Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report. Oncology Letters Diatech Pharmacogenetics2017-09-08T10:00:25+02:00 Read More
24 08, 2017 Annamaria Ruzzo et al., Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. British Journal of Cancer Diatech Pharmacogenetics2017-08-28T16:02:44+02:00 Read More
10 08, 2017 Gianni Bussolati et al., Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. Plos One Diatech Pharmacogenetics2017-08-28T15:42:16+02:00 Read More
19 07, 2017 Marco Lucarelli et al., A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology. The Journal of Molecular Diagnostics Diatech Pharmacogenetics2017-09-04T10:19:00+02:00 Read More
19 07, 2017 Francesca Galuppini et al., BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling. Histopathology Diatech Pharmacogenetics2017-07-19T10:24:11+02:00 Read More
8 07, 2017 Chiara Pesenti et al. Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status Diatech Pharmacogenetics2017-09-14T09:58:04+02:00 Read More
16 06, 2017 Fabiana Pani et al., Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report. Oncology Letters Diatech Pharmacogenetics2017-08-24T15:02:16+02:00 Read More
